معرفی
Georgios Rassidakis is an Adjunct Professor of Pathology at the Department of Oncology-Pathology, Karolinska Institutet in Stockholm, Sweden. He also serves as a senior physician in clinical pathology and cytology at Karolinska University Hospital. His academic and clinical work spans both research and patient care within the field of oncology.
Dr. Rassidakis' research primarily focuses on cancer biology with emphasis on lymphoma, breast cancer, and leukemia. His work spans from basic molecular mechanisms to clinical applications, with significant contributions to understanding protein expression patterns, therapeutic targets, and biomarkers in various malignancies. His laboratory investigates critical pathways including SAMHD1, p53-MDM2 interactions, and immune microenvironment dynamics in cancer progression.
Analysis of his recent publications (2022-2025) reveals a strong focus on translational cancer research, particularly in lymphoma subtypes, breast cancer biomarkers, and therapeutic strategies targeting molecular pathways. His work frequently involves collaboration with international research teams and participation in clinical trials such as the HEAT-AML trial. The research demonstrates consistent themes of molecular diagnostics, targeted therapy development, and understanding mechanisms of treatment resistance.
Dr. Rassidakis has contributed significantly to the field through numerous high-impact publications in journals including Blood, Nature Communications, and Science Immunology. His work has advanced understanding of cancer biology and contributed to potential therapeutic approaches for various malignancies.
